Nuestras cifras y logros del 2022
Echa un vistazo al resumen de nuestras cifras y logros del 2022.
FDA approval of the world’s first gene therapy for Haemophilia
We are incredibly proud to announce the FDA approval of the world’s first #genetherapy for #hemophiliaB. https://lnkd.in/e4SFzMCc
SETGYC 2022 Oral and Poster Award Winners
Congratulations to this year's oral and poster award winners, who presented at the SETGYC Biennial Congress in Sevilla.
